Villers-lès-Nancy, 24 May 2019 - 6:00pm. (CET)
PRESS RELEASE
ANNUAL ORDINARY GENERAL MEETING
Preliminary Notice
PHARMAGEST INTERACTIVE hereby provides notice to shareholders of the Annual Ordinary General Meeting to be held on Thursday, June 27, 2019 at 5.00 pm at the Restaurant Le Clos Jeannon located in VILLERS-LES-NANCY (54600), 2-6 bis Rue Saint Fiacre.
The agenda and draft resolutions have been published in the BALO legal gazette on May 20, 2019 (www.journal-officiel.gouv.fr). The BALO notice can be reviewed on the website of the company (www.pharmagest.com, Finance).
15 days prior to the meeting, a convening notice to attend the meeting will be published in the BALO and in a legal gazette.
Pursuant to article R225-73-1 of the French commercial code, PHARMAGEST INTERACTIVE will publish the documents prescribed by this article on its website 21 days prior to the meeting.
The shareholders may obtain any further information by request to PHARMAGEST INTERACTIVE’s headquarters located in VILLERS-LES-NANCY (54600).
About PHARMAGEST Group:
Pharmagest Group is the French pharmacy information technology leader, with a market share of more than 44% and more than 1,000 employees. The Group's strategy is based on a core business of improving healthcare through information technology innovation and developing two priority areas: 1/ Services and technologies for healthcare professionals, with a focus on assisting pharmacies in patient medication compliance; and 2/ technologies for improving the efficacy of healthcare systems.
This strategy is executed through specialised business lines developed by Pharmagest Group: pharmacy IT solutions, e-Health solutions, solutions for healthcare professionals, solutions for pharmaceutical laboratories, connected health devices and apps, and a sales financing marketplace…
These businesses are grouped within four Divisions: Pharmacy - Europe Solutions; Health and Social Care Facilities Solutions; e-Health Solutions and Fintech.
Listed on Euronext Paris™ - Compartment B
Indices: CAC® SMALL and CAC® All-Tradable par inclusion
Eligible for the Long-Only Deferred Settlement Service (SRD)
ISIN: FR 0012882389 – Reuters: PHA.PA – Bloomberg: - PMGI FP
For all the latest news go to www.pharmagest.com
Follow Pharmagest on Twitter: @Pharmagest, Linkedin and Facebook
CONTACTS
Analyst and Investor Relations:
Chief Administrative and Financial Officer: Jean-Yves SAMSON
Tel. +33 (0)3 83 15 90 67 - jean-yves.samson@lacooperativewelcoop.com
Media Relations:
FIN’EXTENSO – Isabelle APRILE
Tel. +33 (0)1 39 97 61 22 - i.aprile@finextenso.fr
Attachment
